Celerosystems is a company headquartered in the United States.
Celerosystems develops a digital health platform for monitoring, diagnosing, and treating life-threatening conditions such as sleep apnea and opioid risk by tracking cardiac and respiratory vital signs without the need for wearables or wires.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.